UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. The studies are evaluating the safety and effectiveness of two drugs — the investigational antiviral remdesivir, and sarilumab, a drug that blocks the body’s acute inflammatory response.

Read more. 

Media Coverage: Sacramento Business Journal, Yahoo Finance, KCRA, KTVU, Sacramento Bee, Napa Valley Register, Woodland Daily Democrat, KSRO,